Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

52 results about "Idebenone" patented technology

Idebenone (pronounced eye-deb-eh-known, trade names Catena, Raxone, Sovrima, among others) is a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. This has been met with limited success. The Swiss company Santhera Pharmaceuticals has started to investigate it for the treatment of neuromuscular diseases. In 2010, early clinical trials for the treatment of Friedreich's ataxia and Duchenne muscular dystrophy have been completed. As of December 2013 the drug is not approved for these indications in North America or Europe. It is approved by the European Medicines Agency (EMA) for use in Leber's hereditary optic neuropathy (LHON) and was designated an orphan drug in 2007.

Idebenone nanometer lipid carrier transdermal absorption preparation and preparation method thereof

The invention discloses an idebenone nanometer lipid carrier transdermal absorption preparation and a preparation method thereof. The preparation method comprises the following steps: mixing idebenone, solid lipid materials, liquid lipid materials and a surface active agent 1 uniformly, and heating until the mixture is turned into a lipid phase; mixing a surface active agent 2 with ultrapure water uniformly so that the mixture is turned into a water phase; adding the lipid phase into the water phase slowly under the condition of keeping the temperature of the lipid phase and the water phase consistent while stirring; homogenizing rapidly, cutting, carrying out primary emulsification, carrying out ultrasonication again, and cooling down, so that a lipid carrier of a nanometer structure loading idebenone is prepared; and adding pharmaceutically acceptable auxiliary materials, so that the idebenone nanometer lipid carrier transdermal absorption preparation is prepared. The particle diameter of the idebenone nanometer lipid carrier transdermal absorption preparation provided by the invention is 40.2-110.2nm, the entrapment rate is 80.5%-99.1%, the zeta potential is minus 25.5-minus 34.4mV, the morphology is stable, an organic solvent is not contained, the idebenone nanometer lipid carrier transdermal absorption preparation has good compatibility with skin and has no irritation, the first pass effect is avoided, and the bioavailability is improved.
Owner:TIANJIN UNIV

Preparation method for idebenone microcapsule through ultrasonic inclusion by beta-cyclodextrin

The invention discloses a preparation method for an idebenone microcapsule through ultrasonic inclusion by beta-cyclodextrin. The preparation method comprises the following steps: dissolving beta-cyclodextrin in distilled water to prepare a saturated solution, heating the saturated solution of beta-cyclodextrin to a temperature of 30 to 80 DEG C in a water bath and carrying out isothermal stirring for 15 to 50 min; adding idebenone under the condition of isothermal stirring, continuing stirring to realize uniform mixing so as to obtain a mixed solution and subjecting the mixed solution to ultrasonic inclusion so as to obtain a beta-cyclodextrin-idebenone inclusion solution; and standing the beta-cyclodextrin-idebenone inclusion solution at a temperature of 0 to 8 DEG C for 24 h, carrying out pumping filtration and drying to obtain solid powder, grinding the solid powder into fine powder and carrying out sieving so as to obtain the beta-cyclodextrin-idebenone microcapsule. The preparation method provided by the invention overcomes the problem of water-solubility of idebenone and substantially weakens the inherent color of idebenone, so idebenone is compatible with other components in a formula for a cosmetic without influencing the appearance of the cosmetic, thereby greatly enlarging the application scope of IDBN.
Owner:广州保税区雅兰国际化妆品有限公司

Idebenone nanometer lipid carrier transdermal absorption preparation and preparation method thereof

The invention discloses an idebenone nanometer lipid carrier transdermal absorption preparation and a preparation method thereof. The preparation method comprises the following steps: mixing idebenone, solid lipid materials, liquid lipid materials and a surface active agent 1 uniformly, and heating until the mixture is turned into a lipid phase; mixing a surface active agent 2 with ultrapure water uniformly so that the mixture is turned into a water phase; adding the lipid phase into the water phase slowly under the condition of keeping the temperature of the lipid phase and the water phase consistent while stirring; homogenizing rapidly, cutting, carrying out primary emulsification, carrying out ultrasonication again, and cooling down, so that a lipid carrier of a nanometer structure loading idebenone is prepared; and adding pharmaceutically acceptable auxiliary materials, so that the idebenone nanometer lipid carrier transdermal absorption preparation is prepared. The particle diameter of the idebenone nanometer lipid carrier transdermal absorption preparation provided by the invention is 40.2-110.2nm, the entrapment rate is 80.5%-99.1%, the zeta potential is minus 25.5-minus 34.4mV, the morphology is stable, an organic solvent is not contained, the idebenone nanometer lipid carrier transdermal absorption preparation has good compatibility with skin and has no irritation, the first pass effect is avoided, and the bioavailability is improved.
Owner:TIANJIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products